EP3833466 - METHOD AND DEVICE FOR DETERMINING THE CONCENTRATION OF ANALYTES IN WHOLE BLOOD [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.07.2024 Database last updated on 29.10.2024 | |
Former | The patent has been granted Status updated on 11.08.2023 | ||
Former | Grant of patent is intended Status updated on 02.04.2023 | ||
Former | Request for examination was made Status updated on 14.05.2021 | ||
Former | The international publication has been made Status updated on 15.02.2020 | Most recent event Tooltip | 19.07.2024 | No opposition filed within time limit | published on 21.08.2024 [2024/34] | Applicant(s) | For all designated states Siemens Healthcare Diagnostics Inc. 511 Benedict Avenue Tarrytown, NY 10591 / US | [2021/24] | Inventor(s) | 01 /
MEHTA, Kalpesh G615, Aratt Requizza, Gollahalli Electronic City Bangalore 560 100 Karnataka / IN | 02 /
AZHAR, Mohiudeen D306, Sri Ram Signiaa, Neeladri Road Electronic City Bangalore 560 100 Karnataka / IN | [2021/24] | Representative(s) | Schweitzer, Klaus Plate Schweitzer Zounek Patentanwälte Rheingaustrasse 196 65203 Wiesbaden / DE | [2021/24] | Application number, filing date | 19848214.3 | 31.07.2019 | [2021/24] | WO2019US44294 | Priority number, date | US201862715019P | 06.08.2018 Original published format: US 201862715019 P | [2021/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020033192 | Date: | 13.02.2020 | Language: | EN | [2020/07] | Type: | A1 Application with search report | No.: | EP3833466 | Date: | 16.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.02.2020 takes the place of the publication of the European patent application. | [2021/24] | Type: | B1 Patent specification | No.: | EP3833466 | Date: | 13.09.2023 | Language: | EN | [2023/37] | Search report(s) | International search report - published on: | US | 13.02.2020 | (Supplementary) European search report - dispatched on: | EP | 16.07.2021 | Classification | IPC: | G01N21/31, B01L3/00, G01N33/49, G01N33/72, B01D57/02 | [2021/33] | CPC: |
B01L3/502761 (EP,US);
B01L3/502753 (EP,US);
B01D57/02 (EP);
B03C5/005 (US);
B03C5/024 (US);
G01N21/1717 (US);
G01N21/31 (EP,US);
G01N27/44721 (US);
G01N27/44791 (US);
G01N33/4925 (EP,US);
G01N33/721 (EP);
G01N33/726 (EP);
B01L2300/0645 (EP,US);
B01L2300/0822 (EP,US);
B01L2400/0424 (EP,US);
|
Former IPC [2021/24] | B01D57/00, B01D57/02, B01J19/08, B01L3/00, B05C5/00, G01N1/18, G01N33/48 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/24] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERFAHREN UND VORRICHTUNG ZUR BESTIMMUNG DER KONZENTRATION VON ANALYTEN IN VOLLBLUT | [2021/24] | English: | METHOD AND DEVICE FOR DETERMINING THE CONCENTRATION OF ANALYTES IN WHOLE BLOOD | [2021/24] | French: | PROCÉDÉ ET DISPOSITIF POUR DÉTERMINER LA CONCENTRATION D'ANALYTES DANS LE SANG TOTAL | [2023/16] |
Former [2021/24] | PROCÉDÉ ET DISPOSITIF POUR DÉTERMINER DE LA CONCENTRATION D'ANALYTE DANS LE SANG TOTAL | Entry into regional phase | 03.03.2021 | National basic fee paid | 03.03.2021 | Search fee paid | 03.03.2021 | Designation fee(s) paid | 03.03.2021 | Examination fee paid | Examination procedure | 03.03.2021 | Examination requested [2021/24] | 07.02.2022 | Amendment by applicant (claims and/or description) | 03.04.2023 | Communication of intention to grant the patent | 19.07.2023 | Receipt of the translation of the claim(s) | 08.08.2023 | Fee for grant paid | 08.08.2023 | Fee for publishing/printing paid | Opposition(s) | 14.06.2024 | No opposition filed within time limit [2024/34] | Fees paid | Renewal fee | 19.07.2021 | Renewal fee patent year 03 | 19.07.2022 | Renewal fee patent year 04 | 19.07.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 13.09.2023 | CZ | 13.09.2023 | EE | 13.09.2023 | ES | 13.09.2023 | FI | 13.09.2023 | HR | 13.09.2023 | IT | 13.09.2023 | LT | 13.09.2023 | LV | 13.09.2023 | NL | 13.09.2023 | PL | 13.09.2023 | RO | 13.09.2023 | RS | 13.09.2023 | SE | 13.09.2023 | SK | 13.09.2023 | SM | 13.09.2023 | NO | 13.12.2023 | GR | 14.12.2023 | IS | 13.01.2024 | PT | 15.01.2024 | [2024/26] |
Former [2024/25] | AT | 13.09.2023 | |
CZ | 13.09.2023 | ||
EE | 13.09.2023 | ||
ES | 13.09.2023 | ||
FI | 13.09.2023 | ||
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
NL | 13.09.2023 | ||
PL | 13.09.2023 | ||
RO | 13.09.2023 | ||
RS | 13.09.2023 | ||
SE | 13.09.2023 | ||
SK | 13.09.2023 | ||
SM | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
IS | 13.01.2024 | ||
PT | 15.01.2024 | ||
Former [2024/23] | AT | 13.09.2023 | |
CZ | 13.09.2023 | ||
EE | 13.09.2023 | ||
ES | 13.09.2023 | ||
FI | 13.09.2023 | ||
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
NL | 13.09.2023 | ||
RO | 13.09.2023 | ||
RS | 13.09.2023 | ||
SE | 13.09.2023 | ||
SK | 13.09.2023 | ||
SM | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
IS | 13.01.2024 | ||
PT | 15.01.2024 | ||
Former [2024/20] | FI | 13.09.2023 | |
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
NL | 13.09.2023 | ||
RS | 13.09.2023 | ||
SE | 13.09.2023 | ||
SM | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
IS | 13.01.2024 | ||
Former [2024/14] | FI | 13.09.2023 | |
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
NL | 13.09.2023 | ||
RS | 13.09.2023 | ||
SE | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
Former [2024/10] | FI | 13.09.2023 | |
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
RS | 13.09.2023 | ||
SE | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
Former [2024/09] | FI | 13.09.2023 | |
LT | 13.09.2023 | ||
SE | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
Former [2024/08] | LT | 13.09.2023 | |
NO | 13.12.2023 | ||
GR | 14.12.2023 | Documents cited: | Search | [A]JP2013022021 (ASAHI KASEI MEDICAL CO LTD, et al); | [Y]US2016202237 (ZENG HANSONG [US], et al); | [Y]US9535053 (CAFFERTY MICHAEL S [US], et al); | [Y]WO2018065626 (ACOUSORT AB [SE], et al); | International search | [A]US3296922 (HERBERT GOLDBERG); | [A]US5478479 (HERRIG RUSSELL [US]); | [A]WO2008124064 (NETWORK BIOSYSTEMS INC [US], et al); | [X]US8883513 (POLLACK MICHAEL G [US], et al); | [X]US2017248618 (BAXTER ANDREW JOHN [GB], et al); | [AP]US2019054465 (HONG CHIEN-CHONG [TW], et al) | by applicant | US2016202237 | US9535053 | WO2018065626 |